Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/1997
03/20/1997WO1997010212A1 Piperidine compounds as calcium channel blockers
03/20/1997WO1997009997A1 Cystic fibrosis therapy
03/20/1997WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor
03/20/1997CA2232161A1 Diarylalkenylamine derivatives
03/20/1997CA2232089A1 Oligomers which inhibit expression of collagen genes
03/20/1997CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor
03/20/1997CA2231003A1 Benzothiazolone derivatives
03/20/1997CA2185850A1 2-cyano-3-mercaptocrotonamides
03/19/1997EP0763534A1 Arylalkyl-diazinone derivatives as phosphodiesterase IV inhibitors
03/19/1997EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
03/19/1997EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/19/1997EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
03/19/1997EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
03/19/1997EP0763016A1 Compositions and methods for treating mast-cell mediated conditions
03/19/1997EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors
03/19/1997EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same
03/19/1997EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof
03/19/1997EP0626861B1 Treatment for asthma
03/19/1997EP0617610B1 Suspension aerosol formulations
03/19/1997EP0607373B1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
03/19/1997CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity
03/18/1997US5612379 Benzhydrilsulfinyl acetamide for cardiovascular disorders
03/18/1997US5612367 Method of enhancing bioavailability of pharmaceutical agents
03/18/1997US5612359 Substituted biphenyl isoxazole sulfonamides
03/18/1997US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms
03/18/1997US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part
03/18/1997US5612325 Antiinflammatory and immunomodulating effects
03/18/1997US5612314 Nitrosylated neuropeptides
03/13/1997WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997WO1997009046A1 Compounds and methods
03/13/1997WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract
03/13/1997CA2231182A1 Recombinant anti-cd4 antibodies for human therapy
03/12/1997EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof
03/12/1997EP0761232A1 Antiallergic agent comprising anti-PAF receptor antibodies
03/12/1997EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them
03/12/1997EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists
03/12/1997EP0760674A1 Inhibition of infection of mammalian cells by respiratory syncytial virus
03/12/1997EP0760649A1 Fluticasone propionate formulations
03/12/1997EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
03/12/1997CN1145075A Antagonist's of endothelin receptors
03/12/1997CN1145029A Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
03/12/1997CN1144801A Beta-Adrenergic agonists
03/12/1997CN1144800A 3-substituted oxindole derivatives as potassium channel modulators
03/12/1997CN1144657A Artificial snake bile and its manufacture method and usage
03/11/1997US5610285 Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
03/11/1997US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy
03/11/1997US5610176 Tachykinin (NK1) receptor antagonists
03/11/1997US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use
03/11/1997US5610145 Carbamate stereoisomers
03/07/1997CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom
03/06/1997WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/06/1997WO1997008166A1 Piperazino derivatives as neurokinin antagonists
03/06/1997WO1997008133A1 Amide compounds and use of the same
03/06/1997WO1997007796A1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
03/06/1997CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/06/1997CA2502764A1 Amide compounds
03/05/1997EP0760365A2 Alkenyl-benzoylguanidines
03/05/1997EP0759934A1 Neurotensin antagonist peptides
03/05/1997EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/05/1997EP0759768A1 Vasoactive intestinal polypeptide
03/05/1997EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
03/05/1997EP0759751A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
03/05/1997EP0623122B1 Benzopyran and related LTB4-antagonists.
03/05/1997CN1144485A Adhesion inhibiting composition
03/05/1997CN1144128A Pure traditional Chinese medicinal liquor with antisenile action
03/05/1997CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy
03/04/1997US5608095 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/04/1997US5607978 Prostaglandins for vision defects
03/04/1997US5607936 Useful in treatment of respiratory diseases
03/04/1997US5607930 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
02/1997
02/27/1997WO1997007198A2 Dna sequences and secreted proteins encoded thereby
02/27/1997WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists
02/27/1997WO1997006826A1 Gene therapy using ovine adenoviral vectors
02/27/1997WO1997006783A1 Method and composition for treating asthma
02/27/1997DE19531067A1 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität Use of boswellic acid and its derivatives for the inhibition of the normal and increased Leukozytenelastase- or plasmin
02/27/1997CA2229208A1 Dna sequences and secreted proteins encoded thereby
02/27/1997CA2229060A1 Method and composition for treating asthma
02/26/1997EP0759297A1 Remedy for pulmonary heart
02/26/1997EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
02/26/1997EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
02/26/1997EP0758891A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS
02/26/1997EP0758886A1 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders
02/26/1997EP0630382B1 Lactam dipeptides having hle inhibiting activity
02/26/1997CN1143963A Tetracyclic derivatives, process of preparation and use
02/26/1997CN1143956A 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments
02/26/1997CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
02/26/1997CN1143909A Antitussive composition containing antitussive and benzydamine
02/26/1997CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r
02/26/1997CN1143525A Chuanyusan-granule for curing asthmoid respiration
02/25/1997US5605821 Expression control sequences of the P-selectin gene
02/25/1997US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites
02/25/1997CA2183937A1 Alkenyl-benzoylguanidine derivatives
02/25/1997CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives
02/20/1997WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof
02/20/1997WO1997005892A1 Use of betaglycan to reduce scarring
02/20/1997WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
02/20/1997CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
02/20/1997CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof
02/20/1997CA2228650A1 Use of betaglycan to reduce scarring
02/20/1997CA2213773A1 Imidazopyridine derivatives